Aflibercept biosimilar
更新时间：2023-04-03 13:09:22
| 常用名 | 阿柏西普 | CAS号 | 862111-32-8 |
|---|---|---|---|
| 价格 | $需询单/500mg $需询单/1g $需询单/2g $需询单/5g | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情（用途，包装等）
Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept biosimilar is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa. Aflibercept biosimilar is produced in recombinant Chinese hamster ovary (CHO) cells. Aflibercept biosimilar is supplied at a concentration of 40 mg/mL as a sterile, clear, and colorless to pale yellow solution, which contains 10 mM sodium phosphate, 40 mM sodium chloride, 0.03% polysorbate 20, and 5% sucrose, pH 6.2. |